Who has been buying Access Bio stock?

2 distinct insiders have filed 10 disclosed insider purchases in Access Bio (950130), most recently on 2025-10-28. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.

How many insider filings does Access Bio have?

Access Bio has 10 buy-side and 0 sell-side disclosures on record, covering ₩229M ($159K) in total reported value, spanning 2025-10-14 to 2025-10-28.

Do insider buys in Korean stocks predict returns?

Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Access Bio 950130

Company

엑세스바이오Access Bio

Insiders

Buys

Total Value

₩229M ($159K)

Avg Return

-22.23%

Last Filing

2025-10-28

Access Bio (950130) has 10 disclosed insider purchases and 0 disclosed disposals on record, filed by 2 distinct insiders. Together those filings cover ₩229M ($159K) in reported transaction value. The earliest filing StockDrifts holds for Access Bio is dated 2025-10-14; the most recent is 2025-10-28. Across these filings the average return since disclosure is -22.23%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

Date	Type	Source	Insider	Position	Shares	Price at filing	Return	Value
2025-10-28	BUY	Market Buy	박희덕 Park Hee-deok	moving	4.0K	₩4,130	-16.5%	₩17M ($12K)
2025-10-27	BUY	Market Buy	박희덕 Park Hee-deok	moving	2.2K	₩4,005	-13.9%	₩9M ($6K)
2025-10-21	BUY	Market Buy	박희덕 Park Hee-deok	moving	5.4K	₩4,265	-19.1%	₩23M ($16K)
2025-10-20	BUY	Market Buy	박희덕 Park Hee-deok	moving	4.0K	₩4,380	-21.2%	₩17M ($12K)
2025-10-17	BUY	Market Buy	박희덕 Park Hee-deok	moving	3.3K	₩4,375	-21.1%	₩14M ($10K)
2025-10-16	BUY	Market Buy	박희덕 Park Hee-deok	moving	8.3K	₩4,620	-25.3%	₩38M ($27K)
2025-10-15	BUY	Market Buy	박희덕 Park Hee-deok	moving	7.5K	₩4,640	-25.6%	₩35M ($24K)
2025-10-15	BUY	Market Buy	이근형 Lee Geun-hyung	moving	13.0K	₩4,640	-25.6%	₩60M ($42K)
2025-10-15	BUY	Market Buy	박희덕 Park Hee-deok	moving	1.5K	₩4,640	-25.6%	₩7M ($5K)
2025-10-14	BUY	Market Buy	이근형 Lee Geun-hyung	moving	1.5K	₩4,810	-28.3%	₩7M ($5K)
2025-10-14	BUY	신규보고	박희덕 Park Hee-deok	moving	3.0K	₩4,810	-28.3%	₩14M ($10K)
2025-10-14	BUY	신규보고	이근형 Lee Geun-hyung	moving	7.3K	₩4,810	-28.3%	₩35M ($24K)

Frequently asked questions

Who has been buying Access Bio stock?: 2 distinct insiders have filed 10 disclosed insider purchases in Access Bio (950130), most recently on 2025-10-28. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Access Bio have?: Access Bio has 10 buy-side and 0 sell-side disclosures on record, covering ₩229M ($159K) in total reported value, spanning 2025-10-14 to 2025-10-28.
Do insider buys in Korean stocks predict returns?: Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.